Biotechnology
The Biotechnology industry has a total of 595 stocks, with a combined market cap of $1.28 trillion and total revenue of $115.73 billion.
Market Cap
1.28T
Revenue
115.73B
Profits
-39.35B
PE Ratio
n/a
Profit Margin
-34.01%
Dividend Yield
0.04%
595 Stocks
| No. | Symbol | Company Name | Market Cap | % Change | Volume | Revenue |
|---|---|---|---|---|---|---|
| 1 | VRTX | Vertex Pharmaceuticals Incorporated | 127.59B | -2.52% | 61,262 | 12.59B |
| 2 | REGN | Regeneron Pharmaceuticals, Inc. | 79.61B | -1.08% | 32,035 | 15.53B |
| 3 | ARGX | argenx SE | 54.43B | -1.95% | 23,597 | 5.32B |
| 4 | RVMD | Revolution Medicines, Inc. | 43.04B | -0.58% | 92,123 | - |
| 5 | ONC | BeOne Medicines AG | 39.25B | -3.03% | 35,065 | 6.13B |
| 6 | RPRX | Royalty Pharma plc | 33.50B | -0.51% | 101,246 | 2.54B |
| 7 | ALNY | Alnylam Pharmaceuticals, Inc. | 29.54B | -2.81% | 130,072 | 4.80B |
| 8 | INSM | Insmed Incorporated | 27.11B | -1.73% | 175,570 | 1.14B |
| 9 | ROIV | Roivant Sciences Ltd. | 26.23B | 0.11% | 199,013 | 7.53M |
| 10 | MRNA | Moderna, Inc. | 25.02B | -1.52% | 648,254 | 2.23B |
| 11 | INCY | Incyte Corporation | 23.92B | -2.07% | 52,456 | 5.82B |
| 12 | BNTX | BioNTech SE | 22.82B | -1.38% | 75,739 | 3.03B |
| 13 | GMAB | Genmab A/S | 18.65B | -0.45% | 133,197 | 4.13B |
| 14 | ASND | Ascendis Pharma A/S | 16.35B | 0.72% | 50,173 | 1.20B |
| 15 | JAZZ | Jazz Pharmaceuticals plc | 15.73B | -1.41% | 36,358 | 4.60B |
| 16 | BBIO | BridgeBio Pharma, Inc. | 15.48B | -2.49% | 433,083 | 713.07M |
| 17 | BMRN | BioMarin Pharmaceutical Inc. | 13.04B | -1.71% | 85,367 | 3.41B |
| 18 | EXEL | Exelixis, Inc. | 12.46B | -0.63% | 67,910 | 2.44B |
| 19 | CORT | Corcept Therapeutics Incorporated | 12.20B | 2.10% | 74,239 | 830.81M |
| 20 | ARWR | Arrowhead Pharmaceuticals, Inc. | 11.93B | -1.34% | 74,735 | 669.50M |
| 21 | MDGL | Madrigal Pharmaceuticals, Inc. | 11.48B | -2.10% | 14,687 | 1.28B |
| 22 | HALO | Halozyme Therapeutics, Inc. | 11.24B | -1.63% | 133,379 | 1.66B |
| 23 | TECH | Bio-Techne Corporation | 11.24B | -0.10% | 239,204 | 1.22B |
| 24 | AXSM | Axsome Therapeutics, Inc. | 11.12B | -0.63% | 32,201 | 776.57M |
| 25 | SMMT | Summit Therapeutics Inc. | 10.61B | -5.00% | 1,729,261 | - |
| 26 | ABVX | ABIVAX Société Anonyme | 10.60B | -0.97% | 112,511 | 5.67M |
| 27 | APGE | Apogee Therapeutics, Inc. | 10.15B | 0.07% | 84,378 | - |
| 28 | PRAX | Praxis Precision Medicines, Inc. | 10.11B | -1.72% | 20,842 | 7.46M |
| 29 | CYTK | Cytokinetics, Incorporated | 10.10B | -1.06% | 114,650 | 67.67M |
| 30 | PTGX | Protagonist Therapeutics, Inc. | 9.83B | 0.34% | 30,780 | 281.99M |
| 31 | KRYS | Krystal Biotech, Inc. | 9.68B | -0.37% | 22,630 | 440.48M |
| 32 | KYMR | Kymera Therapeutics, Inc. | 9.45B | -0.73% | 39,460 | 105.00M |
| 33 | IONS | Ionis Pharmaceuticals, Inc. | 9.21B | -0.79% | 93,807 | 874.09M |
| 34 | CRNX | Crinetics Pharmaceuticals, Inc. | 8.98B | 0.24% | 427,443 | 42.16M |
| 35 | SYRE | Spyre Therapeutics, Inc. | 8.84B | -1.57% | 102,464 | - |
| 36 | PCVX | Vaxcyte, Inc. | 8.62B | -1.61% | 71,268 | - |
| 37 | IMVT | Immunovant, Inc. | 8.62B | -0.26% | 37,933 | - |
| 38 | IBRX | ImmunityBio, Inc. | 7.89B | -2.75% | 739,522 | 165.79M |
| 39 | RYTM | Rhythm Pharmaceuticals, Inc. | 7.88B | -1.39% | 29,903 | 239.92M |
| 40 | ORKA | Oruka Therapeutics, Inc. | 7.05B | -1.50% | 66,700 | - |
| 41 | TGTX | TG Therapeutics, Inc. | 6.82B | 0.33% | 81,539 | 799.54M |
| 42 | CGON | CG Oncology, Inc. | 6.53B | -1.35% | 44,702 | 6.23M |
| 43 | COGT | Cogent Biosciences, Inc. | 6.46B | -0.19% | 113,398 | - |
| 44 | BLTE | Belite Bio, Inc | 6.39B | -2.27% | 37,086 | - |
| 45 | SRRK | Scholar Rock Holding Corporation | 6.39B | -1.19% | 27,942 | - |
| 46 | MIRM | Mirum Pharmaceuticals, Inc. | 6.30B | -1.79% | 26,654 | 618.07M |
| 47 | ERAS | Erasca, Inc. | 6.22B | -0.45% | 184,198 | - |
| 48 | CAI | Caris Life Sciences, Inc. | 6.17B | -1.62% | 191,082 | 989.61M |
| 49 | DNTH | Dianthus Therapeutics, Inc. | 6.15B | 0.35% | 45,522 | 1.90M |
| 50 | XENE | Xenon Pharmaceuticals Inc. | 6.14B | -1.32% | 46,557 | 7.50M |
| 51 | PTCT | PTC Therapeutics, Inc. | 5.96B | -0.76% | 44,817 | 1.01B |
| 52 | DFTX | Definium Therapeutics, Inc. | 5.75B | -2.44% | 188,003 | - |
| 53 | TVTX | Travere Therapeutics, Inc. | 5.75B | -0.68% | 66,587 | 591.33M |
| 54 | LGND | Ligand Pharmaceuticals Incorporated | 5.74B | -0.27% | 15,351 | 290.54M |
| 55 | CRSP | CRISPR Therapeutics AG | 5.06B | -3.12% | 159,219 | 13.39M |
| 56 | ACAD | ACADIA Pharmaceuticals Inc. | 4.82B | -1.34% | 101,055 | 1.14B |
| 57 | DYN | Dyne Therapeutics, Inc. | 4.78B | -1.50% | 263,634 | - |
| 58 | MANE | Veradermics, Incorporated | 4.65B | 0.30% | 21,606 | - |
| 59 | EWTX | Edgewise Therapeutics, Inc. | 4.58B | -2.43% | 41,864 | - |
| 60 | PBLS | Parabilis Medicines, Inc. | 4.46B | -1.82% | 8,433 | - |
| 61 | CELC | Celcuity Inc. | 4.40B | 4.21% | 255,348 | - |
| 62 | RLAY | Relay Therapeutics, Inc. | 4.31B | -1.30% | 145,493 | 10.35M |
| 63 | TNGX | Tango Therapeutics, Inc. | 4.23B | -2.11% | 145,784 | 53.81M |
| 64 | ELVN | Enliven Therapeutics, Inc. | 4.22B | -0.88% | 20,977 | - |
| 65 | TLX | Telix Pharmaceuticals Limited | 4.01B | -3.97% | 21,797 | 803.79M |
| 66 | GPCR | Structure Therapeutics Inc. | 3.87B | -0.69% | 42,133 | - |
| 67 | DNLI | Denali Therapeutics Inc. | 3.87B | -2.46% | 63,738 | 3.60M |
| 68 | LEGN | Legend Biotech Corporation | 3.85B | -1.73% | 184,181 | 1.27B |
| 69 | VKTX | Viking Therapeutics, Inc. | 3.84B | -0.02% | 137,114 | - |
| 70 | RCUS | Arcus Biosciences, Inc. | 3.59B | -2.22% | 33,873 | 117.00M |
| 71 | IDYA | IDEAYA Biosciences, Inc. | 3.47B | -1.85% | 34,040 | 234.13M |
| 72 | ABCL | AbCellera Biologics Inc. | 3.28B | -2.55% | 1,567,885 | 66.17M |
| 73 | CLDX | Celldex Therapeutics, Inc. | 3.27B | -2.17% | 102,835 | 158.00K |
| 74 | QURE | uniQure N.V. | 3.23B | -1.17% | 103,430 | 18.67M |
| 75 | ARQT | Arcutis Biotherapeutics, Inc. | 3.21B | -1.28% | 138,997 | 463.98M |
| 76 | MBX | MBX Biosciences, Inc. | 3.17B | -1.83% | 24,421 | - |
| 77 | NAMS | NewAmsterdam Pharma Company N.V. | 3.13B | -1.84% | 73,465 | 7.12M |
| 78 | IRON | Disc Medicine, Inc. | 3.03B | -1.26% | 34,950 | - |
| 79 | ALMS | Alumis Inc. | 3.02B | -2.89% | 116,348 | 7.40M |
| 80 | TARS | Tarsus Pharmaceuticals, Inc. | 2.98B | -1.26% | 8,034 | 606.33M |
| 81 | IMNM | Immunome, Inc. | 2.93B | -2.35% | 82,690 | 4.02M |
| 82 | IOVA | Iovance Biotherapeutics, Inc. | 2.92B | -1.15% | 2,043,183 | 324.97M |
| 83 | ZLAB | Zai Lab Limited | 2.89B | -1.17% | 219,477 | 449.61M |
| 84 | NRIX | Nurix Therapeutics, Inc. | 2.74B | -3.05% | 103,993 | 36.77M |
| 85 | ATAI | AtaiBeckley Inc. | 2.69B | 0.14% | 411,706 | 4.47M |
| 86 | BEAM | Beam Therapeutics Inc. | 2.58B | -2.60% | 255,868 | 156.04M |
| 87 | TRVI | Trevi Therapeutics, Inc. | 2.58B | -0.28% | 317,802 | - |
| 88 | RARE | Ultragenyx Pharmaceutical Inc. | 2.54B | -2.12% | 74,419 | 717.00M |
| 89 | NKTR | Nektar Therapeutics | 2.50B | -2.72% | 146,359 | 54.59M |
| 90 | SLS | SELLAS Life Sciences Group, Inc. | 2.48B | -0.49% | 778,085 | - |
| 91 | COAG | Hemab Therapeutics Holdings, Inc. | 2.47B | -1.95% | 8,168 | - |
| 92 | KOD | Kodiak Sciences Inc. | 2.46B | -1.98% | 116,126 | - |
| 93 | VRDN | Viridian Therapeutics, Inc. | 2.45B | -1.68% | 61,505 | 71.13M |
| 94 | PHVS | Pharvaris N.V. | 2.38B | -0.56% | 50,249 | - |
| 95 | URGN | UroGen Pharma Ltd. | 2.31B | -1.91% | 35,965 | 188.73M |
| 96 | KLRA | Kailera Therapeutics, Inc. | 2.30B | -1.17% | 12,119 | - |
| 97 | MLYS | Mineralys Therapeutics, Inc. | 2.28B | -1.34% | 42,622 | - |
| 98 | PVLA | Palvella Therapeutics, Inc. | 2.26B | 0.17% | 13,825 | - |
| 99 | RAPP | Rapport Therapeutics, Inc. | 2.25B | -0.89% | 19,140 | 20.00M |
| 100 | VCEL | Vericel Corporation | 2.25B | -1.26% | 25,907 | 306.30M |
| 101 | VERA | Vera Therapeutics, Inc. | 2.23B | 6.89% | 1,842,304 | - |
| 102 | BHVN | Biohaven Ltd. | 2.22B | -0.81% | 111,839 | - |
| 103 | PGEN | Precigen, Inc. | 2.22B | -4.31% | 695,645 | 85.72M |
| 104 | HRMY | Harmony Biosciences Holdings, Inc. | 2.21B | -1.30% | 37,141 | 959.90M |
| 105 | OCUL | Ocular Therapeutix, Inc. | 2.18B | -1.58% | 161,925 | 52.06M |
| 106 | NUVB | Nuvation Bio Inc. | 2.10B | -1.89% | 696,482 | 169.90M |
| 107 | SEPN | Septerna, Inc. | 2.10B | -0.31% | 106,769 | 98.88M |
| 108 | ADMA | ADMA Biologics, Inc. | 2.10B | -0.53% | 102,228 | 512.28M |
| 109 | MESO | Mesoblast Limited | 2.03B | -5.82% | 31,353 | 65.38M |
| 110 | AUPH | Aurinia Pharmaceuticals Inc. | 2.00B | -1.12% | 76,476 | 311.51M |
| 111 | STOK | Stoke Therapeutics, Inc. | 1.97B | -2.59% | 24,356 | 27.59M |
| 112 | KARD | Kardigan, Inc. | 1.97B | -3.62% | 8,999 | - |
| 113 | GHRS | GH Research PLC | 1.96B | 1.28% | 15,249 | - |
| 114 | AGIO | Agios Pharmaceuticals, Inc. | 1.96B | -2.12% | 45,728 | 98.34M |
| 115 | NBTX | Nanobiotix S.A. | 1.94B | -1.93% | 6,595 | 38.27M |
| 116 | FBRX | Forte Biosciences, Inc. | 1.94B | - | 119,883 | - |
| 117 | ZBIO | Zenas BioPharma, Inc. | 1.93B | 1.47% | 41,560 | 1.00M |
| 118 | GENB | Generate Biomedicines, Inc. | 1.90B | -1.40% | 22,013 | 26.48M |
| 119 | TSHA | Taysha Gene Therapies, Inc. | 1.89B | -3.34% | 137,458 | 5.49M |
| 120 | SRPT | Sarepta Therapeutics, Inc. | 1.89B | -3.04% | 184,704 | 1.97B |
| 121 | DMRA | Damora Therapeutics, Inc. | 1.85B | -2.38% | 12,798 | - |
| 122 | LKFT | Lakefront Biotherapeutics NV | 1.85B | -1.39% | 51,959 | 1.13B |
| 123 | ZYME | Zymeworks Inc. | 1.79B | -2.17% | 48,503 | 37.13M |
| 124 | IMCR | Immunocore Holdings plc | 1.76B | 0.07% | 9,498 | 430.78M |
| 125 | RXRX | Recursion Pharmaceuticals, Inc. | 1.70B | -4.08% | 2,454,026 | 54.86M |
| 126 | XNCR | Xencor, Inc. | 1.70B | -0.65% | 50,868 | 104.97M |
| 127 | SNDX | Syndax Pharmaceuticals, Inc. | 1.69B | -0.58% | 102,623 | 252.25M |
| 128 | AAPG | Ascentage Pharma Group International | 1.69B | - | 84 | 82.08M |
| 129 | BRVE | Braveheart Bio, Inc. | 1.68B | 1.04% | 46,681 | - |
| 130 | ANAB | AnaptysBio, Inc. | 1.67B | 0.46% | 21,405 | 232.39M |
| 131 | FTRE | Fortrea Holdings Inc. | 1.64B | -3.48% | 177,476 | 2.68B |
| 132 | AVLN | Avalyn Pharma Inc. | 1.62B | -0.31% | 17,719 | - |
| 133 | NTLA | Intellia Therapeutics, Inc. | 1.61B | -2.70% | 411,377 | 59.51M |
| 134 | ABSI | Absci Corporation | 1.56B | -3.70% | 369,228 | 1.56M |
| 135 | BCAX | Bicara Therapeutics Inc. | 1.55B | -0.78% | 21,872 | - |
| 136 | TRAX | First Tracks Biotherapeutics, Inc. | 1.53B | -2.91% | 15,808 | - |
| 137 | VIR | Vir Biotechnology, Inc. | 1.51B | -1.11% | 72,512 | 303.23M |
| 138 | JBIO | Jade Biosciences, Inc. | 1.50B | -0.63% | 140,777 | - |
| 139 | INVA | Innoviva, Inc. | 1.50B | 0.10% | 19,621 | 440.00M |
| 140 | MAZE | Maze Therapeutics, Inc. | 1.50B | -2.40% | 10,661 | 20.00M |
| 141 | TYRA | Tyra Biosciences, Inc. | 1.48B | -1.12% | 20,805 | - |
| 142 | AVBP | ArriVent BioPharma, Inc. | 1.47B | -0.35% | 65,912 | - |
| 143 | MRVI | Maravai LifeSciences Holdings, Inc. | 1.46B | -2.94% | 155,842 | 208.78M |
| 144 | LBRX | LB Pharmaceuticals Inc | 1.42B | -0.61% | 10,663 | - |
| 145 | REPL | Replimune Group, Inc. | 1.41B | -0.66% | 343,495 | - |
| 146 | ORIC | ORIC Pharmaceuticals, Inc. | 1.41B | -0.80% | 51,659 | - |
| 147 | MLTX | MoonLake Immunotherapeutics | 1.40B | - | 64,476 | - |
| 148 | SVRA | Savara Inc. | 1.34B | - | 190,852 | - |
| 149 | VOR | Vor Biopharma Inc. | 1.33B | -3.31% | 42,304 | - |
| 150 | GLUE | Monte Rosa Therapeutics, Inc. | 1.33B | -1.52% | 36,768 | 28.73M |
| 151 | DRTS | Alpha Tau Medical Ltd. | 1.32B | -1.38% | 57,134 | - |
| 152 | NVAX | Novavax, Inc. | 1.32B | -1.72% | 252,910 | 413.80M |
| 153 | AKTS | Aktis Oncology, Inc. | 1.32B | 0.17% | 34,973 | 10.06M |
| 154 | INBX | Inhibrx Biosciences, Inc. | 1.29B | -9.18% | 42,719 | 1.30M |
| 155 | IMTX | Immatics N.V. | 1.29B | -1.46% | 18,398 | 43.00M |
| 156 | SPTX | Seaport Therapeutics, Inc. | 1.27B | 0.25% | 4,572 | - |
| 157 | OMER | Omeros Corporation | 1.26B | 0.37% | 522,987 | 38.42M |
| 158 | CRVS | Corvus Pharmaceuticals, Inc. | 1.26B | -1.25% | 75,544 | - |
| 159 | LTGO | Latigo Biotherapeutics, Inc. | 1.25B | -1.77% | 51,869 | - |
| 160 | MNKD | MannKind Corporation | 1.21B | 0.94% | 639,100 | 393.63M |
| 161 | CGEM | Cullinan Therapeutics, Inc. | 1.21B | -4.63% | 55,930 | - |
| 162 | MGTX | MeiraGTx Holdings plc | 1.20B | 2.64% | 49,131 | 397.50M |
| 163 | ANRO | Alto Neuroscience, Inc. | 1.20B | -5.51% | 64,605 | - |
| 164 | EYPT | EyePoint, Inc. | 1.18B | 1.41% | 93,051 | 2.79M |
| 165 | APMD | Apnimed, Inc. | 1.17B | 2.29% | 50,840 | 120.15M |
| 166 | IVA | Inventiva S.A. | 1.10B | -0.87% | 43,962 | 7.94M |
| 167 | SANA | Sana Biotechnology, Inc. | 1.06B | -3.41% | 320,774 | - |
| 168 | WVE | Wave Life Sciences Ltd. | 1.03B | 0.67% | 240,633 | 65.37M |
| 169 | ODTX | Odyssey Therapeutics, Inc. | 1.03B | 3.76% | 17,247 | 99.00K |
| 170 | LXRX | Lexicon Pharmaceuticals, Inc. | 1.03B | -1.28% | 191,502 | 41.47M |
| 171 | AVTX | Avalo Therapeutics, Inc. | 1.01B | -2.88% | 33,953 | 59.00K |
| 172 | ANNX | Annexon, Inc. | 985.81M | -1.14% | 310,128 | - |
| 173 | ARDX | Ardelyx, Inc. | 969.34M | -0.51% | 248,897 | 450.89M |
| 174 | JANX | Janux Therapeutics, Inc. | 965.66M | -1.28% | 41,678 | 24.00M |
| 175 | GERN | Geron Corporation | 960.50M | -2.61% | 475,736 | 204.56M |
| 176 | SLDB | Solid Biosciences Inc. | 948.94M | -2.53% | 74,571 | - |
| 177 | OLMA | Olema Pharmaceuticals, Inc. | 912.60M | -0.76% | 54,749 | - |
| 178 | ABUS | Arbutus Biopharma Corporation | 912.08M | 0.66% | 207,563 | 181.72M |
| 179 | KURA | Kura Oncology, Inc. | 899.39M | 0.20% | 144,382 | 77.23M |
| 180 | DSGN | Design Therapeutics, Inc. | 883.03M | -1.95% | 9,524 | - |
| 181 | TBPH | Theravance Biopharma, Inc. | 878.47M | - | 11,028 | 104.31M |
| 182 | CADL | Candel Therapeutics, Inc. | 860.07M | -4.75% | 342,373 | - |
| 183 | SGP | SpyGlass Pharma, Inc. | 850.75M | 1.05% | 6,808 | - |
| 184 | PHAR | Pharming Group N.V. | 839.41M | -3.97% | 6,375 | 366.48M |
| 185 | ACRS | Aclaris Therapeutics, Inc. | 834.62M | -3.24% | 125,930 | 8.22M |
| 186 | CLYM | Climb Bio, Inc. | 834.55M | -1.36% | 100,610 | - |
| 187 | DBVT | DBV Technologies S.A. | 814.55M | -2.28% | 7,072 | 5.04M |
| 188 | SLN | Silence Therapeutics plc | 814.03M | -3.22% | 77,207 | 615.00K |
| 189 | FTH | Faeth Therapeutics, Inc. | 797.44M | 8.09% | 131,692 | - |
| 190 | OBX | Obsidian Therapeutics, Inc. | 793.31M | -3.22% | 8,280 | - |
| 191 | ATTO | Attovia Therapeutics, Inc. | 789.37M | -4.35% | 21,389 | 1.35M |
| 192 | AURA | Aura Biosciences, Inc. | 789.19M | -0.52% | 86,966 | - |
| 193 | OCS | Oculis Holding AG | 784.61M | -0.86% | 11,906 | 1.45M |
| 194 | RIGL | Rigel Pharmaceuticals, Inc. | 773.53M | 1.52% | 24,487 | 276.79M |
| 195 | DRUG | Bright Minds Biosciences Inc. | 772.26M | -2.55% | 10,007 | - |
| 196 | IMMX | Immix Biopharma, Inc. | 758.32M | -2.93% | 75,227 | - |
| 197 | ACHV | Achieve Life Sciences, Inc. | 738.84M | -0.97% | 121,184 | - |
| 198 | MNPR | Monopar Therapeutics Inc. | 738.67M | -0.33% | 22,793 | - |
| 199 | PHAT | Phathom Pharmaceuticals, Inc. | 729.96M | 0.11% | 50,130 | 239.66M |
| 200 | CTMX | CytomX Therapeutics, Inc. | 719.07M | -1.49% | 110,425 | 18.30M |
| 201 | STTK | Shattuck Labs, Inc. | 716.59M | -2.46% | 140,271 | 1.00M |
| 202 | BBOT | BridgeBio Oncology Therapeutics, Inc. | 714.56M | -3.36% | 31,596 | - |
| 203 | NGNE | Neurogene Inc. | 710.30M | -0.38% | 4,267 | 925.00K |
| 204 | HELP | Cybin Inc. | 706.62M | -0.44% | 205,869 | - |
| 205 | GYRE | Gyre Therapeutics, Inc. | 694.52M | 0.15% | 3,679 | 109.82M |
| 206 | RGNX | REGENXBIO Inc. | 690.83M | -1.83% | 60,719 | 174.48M |
| 207 | CBIO | Crescent Biopharma, Inc. | 690.81M | -2.95% | 9,538 | 11.88M |
| 208 | AGMB | AgomAb Therapeutics NV | 686.52M | -0.04% | 668 | - |
| 209 | ALLO | Allogene Therapeutics, Inc. | 678.89M | -0.76% | 353,347 | 4.64M |
| 210 | ZVRA | Zevra Therapeutics, Inc. | 653.22M | -1.61% | 129,645 | 136.07M |
| 211 | TECX | Tectonic Therapeutic, Inc. | 652.26M | -1.81% | 7,151 | - |
| 212 | FDMT | 4D Molecular Therapeutics, Inc. | 624.81M | -2.92% | 79,788 | 92.01M |
| 213 | NVCT | Nuvectis Pharma, Inc. | 622.31M | -0.68% | 12,410 | - |
| 214 | MDXG | MiMedx Group, Inc. | 606.36M | -0.95% | 50,921 | 355.17M |
| 215 | CRMD | CorMedix Inc. | 599.78M | -5.47% | 357,149 | 462.25M |
| 216 | VSTM | Verastem, Inc. | 592.74M | -1.87% | 115,121 | 87.53M |
| 217 | ASMB | Assembly Biosciences, Inc. | 585.81M | 1.60% | 28,659 | 74.85M |
| 218 | CTNM | Contineum Therapeutics, Inc. | 581.43M | 1.01% | 18,214 | - |
| 219 | ARVN | Arvinas, Inc. | 570.82M | -3.11% | 73,381 | 316.70M |
| 220 | SGMT | Sagimet Biosciences Inc. | 566.89M | -1.72% | 82,866 | - |
| 221 | AUTL | Autolus Therapeutics plc | 566.89M | -4.05% | 385,119 | 117.39M |
| 222 | ALT | Altimmune, Inc. | 558.27M | -0.35% | 558,606 | 31.00K |
| 223 | SPRY | ARS Pharmaceuticals, Inc. | 553.12M | -8.69% | 634,088 | 116.93M |
| 224 | EIKN | Eikon Therapeutics, Inc. | 544.09M | -2.76% | 49,440 | - |
| 225 | OVID | Ovid Therapeutics Inc. | 542.93M | -0.71% | 50,558 | 1.58M |
| 226 | VALN | Valneva SE | 537.13M | 24.78% | 2,136,171 | 163.30M |
| 227 | PRLD | Prelude Therapeutics Incorporated | 535.57M | -2.99% | 23,220 | 22.42M |
| 228 | PRME | Prime Medicine, Inc. | 535.49M | -5.05% | 247,071 | 4.07M |
| 229 | ARTV | Artiva Biotherapeutics, Inc. | 533.15M | -3.50% | 28,714 | 251.00K |
| 230 | MPLT | MapLight Therapeutics, Inc. | 526.46M | 0.26% | 59,325 | - |
| 231 | ZURA | Zura Bio Limited | 524.19M | -2.84% | 82,646 | - |
| 232 | EVMN | Evommune, Inc. | 514.08M | 0.68% | 26,741 | 10.00M |
| 233 | RLMD | Relmada Therapeutics, Inc. | 506.68M | - | 66,135 | - |
| 234 | ANL | Adlai Nortye Ltd. | 502.60M | -2.29% | 1,205 | 5.00M |
| 235 | BLSM | BlossomHill Therapeutics, Inc. | 498.88M | -0.43% | 58,059 | - |
| 236 | ENTX | Entera Bio Ltd. | 496.92M | - | 42,038 | 42.00K |
| 237 | CCCC | C4 Therapeutics, Inc. | 493.95M | -1.59% | 195,964 | 35.04M |
| 238 | KYTX | Kyverna Therapeutics, Inc. | 491.66M | -1.61% | 85,676 | - |
| 239 | OABI | OmniAb, Inc. | 485.60M | -2.62% | 113,079 | 38.46M |
| 240 | RZLT | Rezolute, Inc. | 478.46M | -0.43% | 121,822 | - |
| 241 | DNA | Ginkgo Bioworks Holdings, Inc. | 465.99M | -4.42% | 284,443 | 132.42M |
| 242 | PRTA | Prothena Corporation plc | 460.49M | -1.21% | 15,602 | 54.53M |
| 243 | QTTB | Q32 Bio Inc. | 458.15M | 0.13% | 37,348 | 53.74M |
| 244 | CABA | Cabaletta Bio, Inc. | 452.69M | -1.48% | 355,251 | - |
| 245 | OCGN | Ocugen, Inc. | 445.93M | -2.59% | 374,166 | 4.58M |
| 246 | PBYI | Puma Biotechnology, Inc. | 441.87M | -1.72% | 13,114 | 231.24M |
| 247 | LRMR | Larimar Therapeutics, Inc. | 437.36M | -1.87% | 116,537 | - |
| 248 | EPRX | Eupraxia Pharmaceuticals Inc. | 436.74M | -2.25% | 8,373 | - |
| 249 | SLBT | SL Science Holding Limited | 434.77M | -0.74% | 1,728 | 3.27M |
| 250 | IKT | Inhibikase Therapeutics, Inc. | 434.25M | -1.04% | 15,186 | 1.00 |
| 251 | BNTC | Benitec Biopharma Inc. | 422.21M | -2.15% | 22,382 | - |
| 252 | EDIT | Editas Medicine, Inc. | 420.81M | -2.49% | 249,103 | 47.01M |
| 253 | FENC | Fennec Pharmaceuticals Inc. | 417.43M | -1.20% | 14,300 | 59.22M |
| 254 | PROK | ProKidney Corp. | 415.69M | -2.14% | 319,468 | 818.00K |
| 255 | XFOR | X4 Pharmaceuticals, Inc. | 411.46M | -3.26% | 94,839 | 15.85M |
| 256 | CMPX | Compass Therapeutics, Inc. | 410.60M | 0.88% | 142,473 | 850.00K |
| 257 | AVIR | Atea Pharmaceuticals, Inc. | 408.24M | 0.39% | 36,599 | - |
| 258 | LXEO | Lexeo Therapeutics, Inc. | 396.26M | -2.62% | 34,488 | - |
| 259 | CAPR | Capricor Therapeutics, Inc. | 395.14M | 61.52% | 31,999,574 | 11.13M |
| 260 | FHTX | Foghorn Therapeutics Inc. | 392.10M | 1.74% | 23,697 | 36.74M |
| 261 | ENTA | Enanta Pharmaceuticals, Inc. | 386.49M | -1.26% | 8,568 | 65.26M |
| 262 | VTVT | vTv Therapeutics Inc. | 378.27M | -1.31% | 3,165 | 36.84M |
| 263 | SCTX | Scribe Therapeutics Inc. | 377.29M | -1.82% | 22,121 | 36.28M |
| 264 | UPB | Upstream Bio, Inc. | 375.18M | -0.87% | 27,195 | 3.16M |
| 265 | PALI | Palisade Bio, Inc. | 364.23M | -2.79% | 258,138 | 500.00K |
| 266 | DMAC | DiaMedica Therapeutics Inc. | 362.38M | -0.44% | 10,354 | - |
| 267 | RCKT | Rocket Pharmaceuticals, Inc. | 362.26M | -1.20% | 200,166 | - |
| 268 | STRO | Sutro Biopharma, Inc. | 347.54M | -1.64% | 24,234 | 45.70M |
| 269 | IPSC | Century Therapeutics, Inc. | 344.04M | -1.55% | 72,079 | 109.16M |
| 270 | VCRE | Vicore Pharma Holding AB (publ) | 343.68M | - | 54 | 370.61K |
| 271 | ABEO | Abeona Therapeutics Inc. | 341.96M | -5.75% | 911,148 | 25.52M |
| 272 | SABS | SAB Biotherapeutics, Inc. | 340.74M | -0.13% | 5,359 | 114.70K |
| 273 | CUVL | Clinuvel Pharmaceuticals Limited | 340.01M | - | 21 | 64.24M |
| 274 | LYEL | Lyell Immunopharma, Inc. | 334.25M | -0.73% | 9,219 | 27.00K |
| 275 | IMRX | Immuneering Corporation | 322.84M | -4.04% | 74,733 | - |
| 276 | AGEN | Agenus Inc. | 317.39M | 0.71% | 61,846 | 132.69M |
| 277 | IRD | Opus Genetics, Inc. | 303.58M | -1.91% | 52,920 | 9.86M |
| 278 | FATE | Fate Therapeutics, Inc. | 302.47M | 2.98% | 173,231 | 6.49M |
| 279 | VNDA | Vanda Pharmaceuticals Inc. | 302.31M | -0.60% | 60,462 | 215.72M |
| 280 | TTRX | Turn Therapeutics Inc. | 301.16M | 2.54% | 3,151 | - |
| 281 | NMRA | Neumora Therapeutics, Inc. | 296.45M | -7.51% | 120,391 | - |
| 282 | AVXL | Anavex Life Sciences Corp. | 293.77M | -3.06% | 85,118 | - |
| 283 | IFRX | InflaRx N.V. | 288.84M | -2.49% | 140,808 | -11.54K |
| 284 | SION | Sionna Therapeutics, Inc. | 285.74M | -3.36% | 579,614 | - |
| 285 | SLGL | Sol-Gel Technologies Ltd. | 283.09M | 3.05% | 9,852 | 18.47M |
| 286 | SRZN | Surrozen, Inc. | 282.09M | 1.14% | 6,888 | 11.51M |
| 287 | FULC | Fulcrum Therapeutics, Inc. | 280.32M | -0.97% | 60,886 | 80.00M |
| 288 | ELDN | Eledon Pharmaceuticals, Inc. | 279.45M | -2.30% | 80,490 | - |
| 289 | BCYC | Bicycle Therapeutics plc | 274.37M | -1.51% | 48,713 | 61.21M |
| 290 | ALXO | ALX Oncology Holdings Inc. | 268.95M | 0.26% | 30,005 | - |
| 291 | LCTX | Lineage Cell Therapeutics, Inc. | 268.08M | - | 191,004 | 13.08M |
| 292 | OBIO | Orchestra BioMed Holdings, Inc. | 266.77M | -0.26% | 8,411 | 31.98M |
| 293 | TRDA | Entrada Therapeutics, Inc. | 263.22M | -2.01% | 7,508 | 4.69M |
| 294 | PRQR | ProQR Therapeutics N.V. | 260.37M | -0.27% | 35,683 | 21.05M |
| 295 | RNAC | Cartesian Therapeutics, Inc. | 259.14M | -1.78% | 15,427 | 1.48M |
| 296 | WHWK | Whitehawk Therapeutics, Inc. | 257.97M | -3.31% | 7,443 | 7.15M |
| 297 | ZNTL | Zentalis Pharmaceuticals, Inc. | 254.44M | -14.46% | 1,426,465 | 26.87M |
| 298 | MGNX | MacroGenics, Inc. | 251.71M | -2.94% | 113,707 | 175.14M |
| 299 | ACIU | AC Immune SA | 250.06M | -2.14% | 11,843 | 21.67M |
| 300 | ADAG | Adagene Inc. | 247.77M | 0.81% | 6,306 | 9.29M |
| 301 | NAGE | Niagen Bioscience, Inc. | 239.54M | -0.95% | 18,904 | 129.08M |
| 302 | GLSI | Greenwich LifeSciences, Inc. | 237.35M | -1.28% | 8,957 | - |
| 303 | IPHA | Innate Pharma S.A. | 237.30M | -16.31% | 55,246 | 10.57M |
| 304 | CLLS | Cellectis S.A. | 233.16M | -2.36% | 12,469 | 63.82M |
| 305 | ARCT | Arcturus Therapeutics Holdings Inc. | 229.37M | 2.67% | 143,052 | 29.37M |
| 306 | TARA | Protara Therapeutics, Inc. | 227.52M | -2.28% | 36,045 | - |
| 307 | CAMP | Camp4 Therapeutics Corporation | 225.88M | -3.33% | 18,604 | 4.22M |
| 308 | ANTX | AN2 Therapeutics, Inc. | 225.66M | - | 12,863 | - |
| 309 | CNXU | Conexeu Sciences Inc. | 225.57M | 5.77% | 21,008 | - |
| 310 | CGEN | Compugen Ltd. | 225.44M | -1.24% | 25,785 | 74.00M |
| 311 | IMUX | Immunic, Inc. | 219.17M | -2.96% | 16,012 | - |
| 312 | ALEC | Alector, Inc. | 218.85M | -3.92% | 61,725 | 13.86M |
| 313 | NBP | NovaBridge Biosciences | 215.11M | -2.11% | 46,731 | - |
| 314 | VOGX | Vogenx, Inc. | 214.68M | 9.47% | 10,442 | - |
| 315 | GALT | Galectin Therapeutics Inc. | 214.03M | -7.93% | 66,286 | - |
| 316 | NERV | Minerva Neurosciences, Inc. | 212.00M | 13.27% | 70,220 | - |
| 317 | TNXP | Tonix Pharmaceuticals Holding Corp. | 209.24M | -2.40% | 29,390 | 29.10M |
| 318 | RNA | Atrium Therapeutics, Inc. | 208.69M | -1.05% | 15,883 | 36.68M |
| 319 | MSLE | Satellos Bioscience Inc. | 206.96M | -0.46% | 3,396 | - |
| 320 | KROS | Keros Therapeutics, Inc. | 204.81M | -3.10% | 15,419 | 15.01M |
| 321 | DTIL | Precision BioSciences, Inc. | 199.28M | -1.10% | 11,140 | 45.06M |
| 322 | PEPG | PepGen Inc. | 198.02M | -4.06% | 65,771 | - |
| 323 | IVVD | Invivyd, Inc. | 197.39M | -2.29% | 311,211 | 58.37M |
| 324 | ACOG | Alpha Cognition Inc. | 195.97M | 4.29% | 81,977 | 10.83M |
| 325 | CRBP | Corbus Pharmaceuticals Holdings, Inc. | 194.77M | -0.10% | 45,847 | - |
| 326 | VYGR | Voyager Therapeutics, Inc. | 194.71M | -1.86% | 44,556 | 34.46M |
| 327 | KRRO | Korro Bio, Inc. | 191.29M | -2.26% | 5,756 | 2.38M |
| 328 | PYXS | Pyxis Oncology, Inc. | 187.85M | -1.50% | 76,716 | 11.04M |
| 329 | PLX | Protalix BioTherapeutics, Inc. | 183.70M | -3.39% | 284,876 | 80.62M |
| 330 | ORMP | Oramed Pharmaceuticals Inc. | 180.53M | -0.91% | 24,353 | 2.00M |
| 331 | ABOS | Acumen Pharmaceuticals, Inc. | 180.07M | -2.35% | 30,482 | - |
| 332 | YDES | YD Bio Limited | 179.32M | 1.59% | 636 | 510.36K |
| 333 | NGEN | NervGen Pharma Corp. | 177.71M | -5.11% | 131,879 | - |
| 334 | CHRS | Coherus Oncology, Inc. | 177.68M | 0.88% | 57,679 | 50.94M |
| 335 | MDWD | MediWound Ltd. | 173.90M | -0.44% | 7,391 | 11.86M |
| 336 | CDXS | Codexis, Inc. | 168.64M | -3.75% | 129,212 | 77.68M |
| 337 | ARMP | Armata Pharmaceuticals, Inc. | 168.43M | -6.02% | 9,493 | 5.54M |
| 338 | TNYA | Tenaya Therapeutics, Inc. | 164.74M | 0.23% | 375,420 | 1.34M |
| 339 | NKTX | Nkarta, Inc. | 162.95M | -1.09% | 66,107 | - |
| 340 | HUMA | Humacyte, Inc. | 157.68M | 6.33% | 4,953,250 | 2.12M |
| 341 | OKUR | OnKure Therapeutics, Inc. | 155.51M | -1.54% | 6,502 | - |
| 342 | CRBU | Caribou Biosciences, Inc. | 154.72M | -3.11% | 327,548 | 10.04M |
| 343 | CNTB | Connect Biopharma Holdings Limited | 154.29M | -3.54% | 11,760 | 2.95M |
| 344 | OTLK | Outlook Therapeutics, Inc. | 153.37M | -7.72% | 8,539,858 | 333.14K |
| 345 | MENS | Jyong Biotech Ltd. | 152.92M | - | 5,048 | - |
| 346 | UNCY | Unicycive Therapeutics, Inc. | 151.53M | 0.74% | 123,825 | - |
| 347 | MOLN | Molecular Partners AG | 149.11M | -0.48% | 104 | 856.30K |
| 348 | CNTN | Canton Strategic Holdings, Inc. | 148.85M | -2.03% | 14,744 | - |
| 349 | KZIA | Kazia Therapeutics Limited | 148.66M | -1.51% | 2,208 | 1.27M |
| 350 | LENZ | LENZ Therapeutics, Inc. | 148.62M | 2.83% | 89,604 | 21.48M |
| 351 | SPRB | Spruce Biosciences, Inc. | 144.85M | 1.27% | 1,570 | 697.00K |
| 352 | MIST | Milestone Pharmaceuticals Inc. | 142.85M | -1.87% | 432,411 | 2.34M |
| 353 | HURA | TuHURA Biosciences, Inc. | 142.85M | -2.47% | 28,821 | - |
| 354 | TLSA | Tiziana Life Sciences Ltd | 140.95M | 4.81% | 45,955 | - |
| 355 | CUE | Cue Biopharma, Inc. | 139.49M | 6.85% | 5,889 | 32.73M |
| 356 | AARD | Aardvark Therapeutics, Inc. | 137.44M | -2.03% | 7,890 | - |
| 357 | PMN | ProMIS Neurosciences, Inc. | 137.03M | 3.31% | 3,769 | - |
| 358 | EQ | Equillium, Inc. | 135.94M | 6.97% | 75,574 | 4.39M |
| 359 | NRXP | NRx Pharmaceuticals, Inc. | 133.69M | -4.49% | 407,992 | 2.29M |
| 360 | INDP | Indaptus Therapeutics, Inc. | 130.22M | 8.48% | 18,711 | - |
| 361 | CBUS | Cibus, Inc. | 125.18M | -13.68% | 148,787 | 4.35M |
| 362 | YARW | Yarrow Bioscience, Inc. | 119.01M | -0.50% | 317 | - |
| 363 | PLYX | Polaryx Therapeutics, Inc. | 118.36M | - | 43,280 | - |
| 364 | SEER | Seer, Inc. | 116.72M | 0.48% | 36,348 | 14.22M |
| 365 | VANI | Vivani Medical, Inc. | 116.42M | 0.75% | 11,725 | - |
| 366 | GNLX | Genelux Corporation | 115.46M | -1.14% | 4,523 | 8.00K |
| 367 | BDTX | Black Diamond Therapeutics, Inc. | 113.76M | -1.98% | 51,301 | 70.00M |
| 368 | ENGN | enGene Therapeutics Inc. | 112.21M | -0.89% | 36,052 | - |
| 369 | NAUT | Nautilus Biotechnology, Inc. | 112.13M | -0.99% | 110,941 | 190.00K |
| 370 | COYA | Coya Therapeutics, Inc. | 106.96M | -2.36% | 24,678 | 8.02M |
| 371 | RANI | Rani Therapeutics Holdings, Inc. | 106.36M | -2.24% | 158,022 | 3.17M |
| 372 | ANIX | Anixa Biosciences, Inc. | 106.15M | -2.50% | 44,789 | - |
| 373 | GUTS | Fractyl Health, Inc. | 105.68M | 0.62% | 195,637 | 3.00K |
| 374 | TENX | Tenax Therapeutics, Inc. | 103.11M | -1.64% | 1,248,978 | - |
| 375 | INO | Inovio Pharmaceuticals, Inc. | 101.97M | 3.32% | 841,484 | 65.34K |
| 376 | NTHI | NeOnc Technologies Holdings, Inc. | 100.36M | 20.56% | 86,038 | 39.99K |
| 377 | PTHS | Pelthos Therapeutics Inc. | 97.32M | -3.28% | 622 | 43.30M |
| 378 | PYPD | PolyPid Ltd. | 97.09M | - | 5,804 | - |
| 379 | CGTX | Cognition Therapeutics, Inc. | 95.08M | -3.86% | 117,848 | - |
| 380 | ONCY | Oncolytics Biotech Inc. | 94.33M | -1.21% | 55,863 | - |
| 381 | BMEA | Biomea Fusion, Inc. | 92.78M | - | 37,830 | - |
| 382 | KLRS | Kalaris Therapeutics, Inc. | 92.31M | - | 7,378 | - |
| 383 | ICCC | ImmuCell Corporation | 92.19M | -6.51% | 13,597 | 29.93M |
| 384 | FBIO | Fortress Biotech, Inc. | 91.68M | -7.38% | 219,553 | 68.47M |
| 385 | GANX | Gain Therapeutics, Inc. | 91.28M | -1.15% | 55,575 | - |
| 386 | RLYB | Rallybio Corporation | 89.32M | -0.83% | 2,973 | 646.00K |
| 387 | ACET | Adicet Bio, Inc. | 88.91M | - | 7,095 | - |
| 388 | ALDX | Aldeyra Therapeutics, Inc. | 88.08M | 1.39% | 138,498 | - |
| 389 | ATHE | Alterity Therapeutics Limited | 83.69M | 0.64% | 1,518 | 4.43M |
| 390 | VRCA | Verrica Pharmaceuticals Inc. | 83.32M | -0.21% | 4,659 | 30.32M |
| 391 | MAIA | MAIA Biotechnology, Inc. | 83.30M | 2.24% | 88,433 | - |
| 392 | ACRV | Acrivon Therapeutics, Inc. | 81.75M | 3.24% | 126,858 | - |
| 393 | GOSS | Gossamer Bio, Inc. | 80.66M | -3.11% | 2,378,902 | 55.54M |
| 394 | OKYO | OKYO Pharma Limited | 79.77M | 0.66% | 9,754 | - |
| 395 | ANVS | Annovis Bio, Inc. | 79.55M | 4.47% | 95,832 | - |
| 396 | NRXS | NeurAxis, Inc. | 78.15M | 0.48% | 2,285 | 5.32M |
| 397 | ELOX | Eloxx Pharmaceuticals, Inc. | 76.69M | -0.37% | 2,261 | - |
| 398 | ATRA | Atara Biotherapeutics, Inc. | 74.33M | -3.06% | 830 | 6.19M |
| 399 | LONA | LeonaBio, Inc. | 73.93M | - | 169 | - |
| 400 | TELO | Telomir Pharmaceuticals, Inc. | 73.40M | 1.64% | 4,815 | - |
| 401 | ELTX | Elicio Therapeutics, Inc. | 72.70M | -1.59% | 25,887 | - |
| 402 | SPRO | Spero Therapeutics, Inc. | 72.38M | 0.81% | 24,645 | 47.00M |
| 403 | XBIT | XBiotech Inc. | 71.04M | - | 53 | - |
| 404 | OSTX | OS Therapies Incorporated | 70.37M | -1.25% | 74,469 | - |
| 405 | CSBR | Champions Oncology, Inc. | 68.77M | -2.56% | 23,632 | 59.43M |
| 406 | IBIO | iBio, Inc. | 67.07M | -3.57% | 58,513 | 300.00K |
| 407 | RNTX | Rein Therapeutics Inc. | 66.72M | -0.95% | 21,064 | - |
| 408 | IMA | ImageneBio, Inc. | 66.63M | - | 24 | 800.00K |
| 409 | PMVP | PMV Pharmaceuticals, Inc. | 66.40M | 2.47% | 21,477 | - |
| 410 | CRDF | Cardiff Oncology, Inc. | 66.39M | -1.32% | 65,970 | 508.00K |
| 411 | PLRX | Pliant Therapeutics, Inc. | 65.95M | -1.39% | 2,989 | - |
| 412 | MNOV | MediciNova, Inc. | 65.46M | 1.53% | 2,591 | 920.48K |
| 413 | DWTX | Dogwood Therapeutics, Inc. | 65.32M | -1.90% | 5,483 | - |
| 414 | HYFT | MindWalk Holdings Corp. | 64.37M | -1.44% | 11,592 | 11.43M |
| 415 | CING | Cingulate Inc. | 64.25M | -4.41% | 32,125 | - |
| 416 | BOLD | Boundless Bio, Inc. | 63.69M | 0.90% | 1,410 | - |
| 417 | HRTX | Heron Therapeutics, Inc. | 62.65M | -1.32% | 118,168 | 151.18M |
| 418 | RNXT | RenovoRx, Inc. | 59.08M | 3.97% | 68,598 | 1.98M |
| 419 | INMB | INmune Bio Inc. | 56.90M | -1.44% | 33,060 | 50.00K |
| 420 | INKT | MiNK Therapeutics, Inc. | 56.64M | 3.36% | 837 | - |
| 421 | ALPS | Alps Group Inc | 55.71M | 2.07% | 316 | 3.74M |
| 422 | EDSA | Edesa Biotech, Inc. | 54.81M | 4.79% | 5,947 | - |
| 423 | ATYR | aTyr Pharma, Inc. | 54.74M | 0.91% | 158,438 | 190.00K |
| 424 | EXOZ | eXoZymes, Inc. | 54.66M | - | 42 | -700.00 |
| 425 | XLO | Xilio Therapeutics, Inc. | 54.65M | 1.39% | 241 | 64.09M |
| 426 | BSEM | BioStem Technologies, Inc. | 54.24M | -1.29% | 16,729 | 91.15M |
| 427 | IMMP | Immutep Limited | 54.10M | -0.87% | 5,783 | 5.28M |
| 428 | TIL | Instil Bio, Inc. | 49.58M | 0.55% | 833 | - |
| 429 | TCRX | TScan Therapeutics, Inc. | 49.01M | -2.85% | 25,441 | 7.11M |
| 430 | VRXA | Veraxa Biotech AG | 47.91M | 0.53% | 2,510 | - |
| 431 | MREO | Mereo BioPharma Group plc | 47.26M | -3.77% | 229,078 | 500.00K |
| 432 | CNTX | Context Therapeutics Inc. | 47.24M | 1.52% | 99,184 | - |
| 433 | MGX | Metagenomi Therapeutics, Inc. | 45.71M | -1.63% | 24,442 | 13.56M |
| 434 | KPTI | Karyopharm Therapeutics Inc. | 44.99M | -0.25% | 52,422 | 146.62M |
| 435 | IBO | Impact BioMedical Inc. | 44.69M | -5.80% | 6,919 | 35.00K |
| 436 | FLNA | Filana Therapeutics, Inc. | 44.68M | -2.22% | 74,979 | - |
| 437 | MCRB | Seres Therapeutics, Inc. | 44.34M | -0.45% | 4,522 | 1.88M |
| 438 | CRVO | CervoMed Inc. | 43.77M | -1.19% | 73,421 | 331.30K |
| 439 | GRCE | Grace Therapeutics, Inc. | 43.33M | -0.48% | 79,079 | - |
| 440 | HYPD | Hyperion DeFi, Inc. | 42.74M | -0.35% | 48,817 | 1.40M |
| 441 | VERU | Veru Inc. | 42.53M | -1.85% | 15,022 | 16.89M |
| 442 | ALGS | Aligos Therapeutics, Inc. | 41.21M | -2.51% | 7,696 | 31.52M |
| 443 | SER | Serina Therapeutics, Inc. | 40.49M | -5.26% | 10,637 | 130.00K |
| 444 | NTRB | Nutriband Inc. | 38.60M | -0.47% | 748 | 1.80M |
| 445 | APLM | Apollomics, Inc. | 38.15M | - | 330 | 8.84M |
| 446 | RADX | Radiopharm Theranostics Limited | 36.75M | -5.66% | 32,276 | 10.86M |
| 447 | NXTC | NextCure, Inc. | 35.34M | -6.76% | 48,202 | - |
| 448 | BYSI | BeyondSpring Inc. | 33.87M | -17.32% | 384,551 | 1.88M |
| 449 | QNCX | Quince Therapeutics, Inc. | 33.21M | 4.78% | 5,910 | - |
| 450 | LTRN | Lantern Pharma Inc. | 32.15M | -4.18% | 39,920 | - |
| 451 | GNTA | Genenta Science S.p.A. | 31.85M | 3.85% | 6,359 | - |
| 452 | ESLA | Estrella Immunopharma, Inc. | 31.64M | 1.46% | 188 | - |
| 453 | NNVC | NanoViricides, Inc. | 30.96M | -0.07% | 44,023 | - |
| 454 | ATNM | Actinium Pharmaceuticals, Inc. | 30.66M | 1.17% | 47,582 | 35.09M |
| 455 | LITS | Lite Strategy, Inc. | 30.05M | -1.37% | 329 | - |
| 456 | BCTX | BriaCell Therapeutics Corp. | 29.95M | -0.64% | 5,637 | - |
| 457 | IGC | IGC Pharma, Inc. | 29.16M | -0.92% | 490,970 | 1.11M |
| 458 | KYNB | Kyntra Bio, Inc. | 28.97M | 1.67% | 3,803 | 4.62M |
| 459 | ENLV | Enlivex Ltd. | 28.68M | -2.96% | 76,097 | - |
| 460 | GRDX | GridAI Technologies Corp. | 28.32M | 5.54% | 16,294 | - |
| 461 | DYAI | Dyadic International, Inc. | 27.80M | -0.92% | 43,969 | 3.80M |
| 462 | TVGN | Tevogen Inc. | 27.72M | - | 576 | - |
| 463 | EVAX | Evaxion A/S | 26.94M | 0.59% | 2,467 | 7.53M |
| 464 | CVM | CEL-SCI Corporation | 26.74M | 2.68% | 18,925 | - |
| 465 | ATOS | Atossa Therapeutics, Inc. | 24.55M | -3.91% | 11,792 | - |
| 466 | BRNS | Barinthus Biotherapeutics plc | 24.51M | - | 145 | 14.97M |
| 467 | CNSY | Cerenome, Inc. | 24.47M | -3.92% | 30,665 | 5.18M |
| 468 | JSPR | Jasper Therapeutics, Inc. | 23.75M | -1.77% | 40,052 | - |
| 469 | ACTU | Actuate Therapeutics, Inc. | 23.37M | 0.16% | 13,442 | - |
| 470 | LGVN | Longeveron Inc. | 22.44M | 1.78% | 24,442 | 1.19M |
| 471 | ALLR | Allarity Therapeutics, Inc. | 22.28M | 2.95% | 3,938 | 345.00K |
| 472 | ABVC | ABVC BioPharma, Inc. | 21.98M | -9.33% | 44,624 | 797.92K |
| 473 | DARE | Daré Bioscience, Inc. | 21.12M | 2.92% | 1,704,192 | 1.16M |
| 474 | QNTM | Quantum BioPharma Ltd. | 20.70M | 6.81% | 33,422 | - |
| 475 | NEUP | Neuphoria Therapeutics Inc. | 20.70M | - | 598 | -13.27K |
| 476 | CLRB | Cellectar Biosciences, Inc. | 20.62M | 4.03% | 3,030 | - |
| 477 | COCP | Cocrystal Pharma, Inc. | 20.61M | -2.73% | 2,446 | 330.00K |
| 478 | PLRZ | Polyrizon Ltd. | 20.59M | 2.33% | 7,427 | - |
| 479 | CELU | Celularity Inc. | 20.13M | - | 1,690 | 26.55M |
| 480 | CTXR | Citius Pharmaceuticals, Inc. | 20.10M | -0.22% | 47,853 | 5.61M |
| 481 | HOWL | Werewolf Therapeutics, Inc. | 19.42M | 3.52% | 37,329 | 21.00M |
| 482 | MRKR | Marker Therapeutics, Inc. | 19.17M | 3.60% | 10,667 | 3.55M |
| 483 | TVRD | Tvardi Therapeutics, Inc. | 18.95M | 14.12% | 79,595 | - |
| 484 | PTN | Palatin Technologies, Inc. | 18.84M | -5.90% | 3,619 | 12.88M |
| 485 | SKYE | Skye Bioscience, Inc. | 18.63M | -2.00% | 610 | - |
| 486 | PLUR | Pluri Inc. | 18.34M | 2.32% | 723 | 1.08M |
| 487 | CYCN | Cyclerion Therapeutics, Inc. | 17.74M | -1.53% | 2,509 | 1.90M |
| 488 | LPCN | Lipocine Inc. | 17.31M | 1.94% | 1,834 | 1.57M |
| 489 | NCEL | NewcelX Ltd. | 17.12M | -11.67% | 39,323 | - |
| 490 | TPST | Tempest Therapeutics, Inc. | 16.94M | -9.40% | 67,433 | - |
| 491 | KALA | KALA BIO, Inc. | 16.92M | -1.52% | 4,911 | - |
| 492 | NRSN | NeuroSense Therapeutics Ltd. | 16.71M | 2.01% | 19,527 | - |
| 493 | KTTA | Pasithea Therapeutics Corp. | 15.97M | - | 9,259 | - |
| 494 | HIND | Vyome Holdings, Inc. | 15.65M | 3.24% | 1,445 | 129.73K |
| 495 | PASG | Passage Bio, Inc. | 14.68M | - | 388 | - |
| 496 | MLEC | Moolec Science SA | 14.54M | - | 105 | 7.83M |
| 497 | CMMB | Chemomab Therapeutics Ltd. | 13.80M | 0.84% | 3,340 | - |
| 498 | LEXX | Lexaria Bioscience Corp. | 13.45M | 0.46% | 3,000 | 194.00K |
| 499 | PBM | Psyence Biomedical Ltd. | 13.39M | -1.40% | 3,007 | - |
| 500 | PDSB | PDS Biotechnology Corporation | 13.37M | 2.74% | 364,995 | - |